Banner Image

Banner Image

Press Release Details

Home / Investors / Press Releases/

GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepiro...

GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen

October 31, 2023

GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen 240.1 KB